Evaluation of Immunogenicity and Safety of the New Tetanus-Reduced Diphtheria (Td) Vaccines (GC1107) in Healthy Korean Adolescents: A Phase II, Double-Blind, Randomized, Multicenter Clinical Trial

This phase II clinical trial was conducted to compare the immunogenicity and safety of a newly developed tetanus-reduced diphtheria (Td) vaccine (GC1107-T5.0 and GC1107-T7.5) and control vaccine. This study was also performed to select the proper dose of tetanus toxoid in the new Td vaccines. Health...

Descripción completa

Detalles Bibliográficos
Autores principales: Rhim, Jung-Woo, Lee, Kyung-Yil, Kim, Sang-Yong, Kim, Jong-Hyun, Kim, Hyun-Hee, Kim, Hwang Min, Choi, Young-Youn, Ma, Sang-Hyuk, Kim, Dong-Ho, Ahn, Dong Ho, Kang, Jin-Han
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Academy of Medical Sciences 2013
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3617313/
https://www.ncbi.nlm.nih.gov/pubmed/23579367
http://dx.doi.org/10.3346/jkms.2013.28.4.586

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3617313/
https://www.ncbi.nlm.nih.gov/pubmed/23579367
http://dx.doi.org/10.3346/jkms.2013.28.4.586

Ejemplares similares